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WHAT IS SPECIALISED COMMISSIONING?
In the UK, almost 15% of the annual healthcare
budget is set aside by the National Health Service
(NHS) for specialised services. This signiﬁcant
resource (£14 billion last year) is directed towards a
clearly deﬁned pool of uncommon and complex
conditions, and speciﬁcally supports small numbers
of ‘centres of excellence’ with large catchment areas.
In respiratory medicine, specialised commissioning
has funded services for cystic ﬁbrosis and pulmonary
hypertension for some years. However, variations in
commissioning arrangements for other complex
conditions have led to variable service provision. In
2013, NHS England (NHSE) produced service spe-
ciﬁcations for an additional set of respiratory condi-
tions, including severe asthma1 (ﬁgure 1), and these
have fuelled a good deal of debate.
WHY SPECIALISED COMMISSIONING FOR
ASTHMA?
We all recognise asthma to be a major source of
physical and psychological morbidity and of indir-
ect and healthcare expenditure. Indeed, preventa-
tive inhaler therapy is the largest drug cost faced by
the NHS. It came as little surprise to us that the
recent National Review of Asthma Deaths revealed
failings across the whole spectrum of asthma care,2
with this report and other publications (such as the
NHS Atlas of Variation3) also highlighting dispar-
ities in outcomes across the country.
A small subset of asthmatics have severe,
treatment-resistant disease. These individuals
require expert, multidisciplinary team (MDT)
assessment to comprehensively characterise their
disease, evaluate psychological burden and tailor
treatments, some of which may be high-cost therap-
ies (such as monoclonal antibodies or bronchial
thermoplasty) or treatment for complex issues such
as vocal cord dysfunction or dysfunctional breath-
ing. Current UK service provision is patchy, with
some regions having multiple Trusts that run
special-interest severe asthma clinics, with others
having a single regional clinic for what maybe a
similar-sized population. Furthermore, care within
or between regions is not standardised.
We believe this current fragmented UK model of
severe asthma care is not equitable for patients and
is not sustainable clinically in view of the projected
NHS funding gap. First, it is untenable for every
UK Trust currently providing an ‘asthma clinic’ to
develop and deliver a comprehensive specialist
service with the ﬁnite resources available. Second,
initial attempts to pool knowledge across severe
asthma centres through the British Thoracic Society
Severe Asthma Registry have further emphasised
the beneﬁts of sharing data and standardising pro-
cedures to improve outcomes4 5 and prevent over-
prescribing of expensive or toxic therapies.6 Third,
increasing coordination of research across specialist
centres affords a realistic opportunity to improve
severe asthma management through large-scale
investigator-led studies, such as the recent medical
reaserch centre (MRC) supported UK Refractory
Asthma Stratiﬁcation (RASP-UK) programme.7 The
ethos behind specialist commissioning is to provide
equitable, high-quality care to patients with severe
asthma in high-volume centres irrespective of
postcode.
BARRIERS TO SUCCESSFUL IMPLEMENTATION
Who has severe asthma?
Successful models of commissioning exist for ser-
vices where end-users are readily identiﬁed either
by the nature of the intervention (eg, one either
has or has not had a lung transplant) or by the
accepted objective threshold (eg, pulmonary hyper-
tension). Severe asthma differs in that there is no
single objective diagnostic test. Therefore, there is a
considerable challenge in identifying from the mil-
lions of asthmatics, those who truly have
treatment-resistant severe asthma rather than ‘difﬁ-
cult asthma’ due to physical and psychological
comorbidity and environmental factors. This is a
particular issue in areas where there remains an
excessive reliance on reported symptoms rather
than objective measures.
The potential to exacerbate inequalities
Since the release of the service speciﬁcation, ques-
tions have been raised as to how a small number of
centres could cater for all eligible patients across
England. In other disease areas, centralised services
increase the practical hardship of travel for
patients8 9 and can be associated with delayed inter-
vention.10 This appears to be a particular issue in
geographically larger and less afﬂuent regions.11
The increased practical or ﬁnancial challenges of
travelling to a specialist clinic may therefore dis-
courage some individuals from accessing services in
a timely and regular fashion.
Who is special?
In recent formal consultations and informal discus-
sions, some healthcare professionals have expressed
to the authors reservations over the perceived cen-
tralisation of ‘specialised’ services, and that some
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have not engaged (or been engaged) in discussions. Although
everyone wants to see the best service available to all patients,
some feel there is insufﬁcient evidence to support fully centra-
lised care. There is particular concern about the potential effect
on local services that have many years of experience of running
an asthma clinic, on both the local population and the medical
training. During discussions, those who run busy asthma services
in district general hospitals have expressed a perception that key
policy inﬂuencers tend to be academics from teaching hospitals
who see a select group of patients away from the ‘front line’,
and these individuals may not be representative of the wider
‘difﬁcult asthma’ population. This is an interesting clash of view-
points. We would argue that while it is clear that consultants in
current specialist centres see a much higher volume of patients
with severe asthma than their counterparts in district general
hospitals, overall the burden of ‘difﬁcult’ asthma is higher
outside of specialist centres. Therefore, there is a requirement
for expertise in the wider setting. However, this expertise
should probably be complementary to that in specialist centres
rather than attempting to widely ‘upskill’ physicians in non-
specialist hospitals: severe asthma is becoming ever more
complex with advances in endotyping, new biomarkers becom-
ing available and plethora of potentially costly biologics on the
horizon. In order to maintain excellence in quality of care and
ﬁnancial sustainability, services may be better delivered in high-
volume specialist centres. These types of differences in opinion
and viewpoints are inevitable when, over the years, independent
local services have evolved in the absence of a national focus
and create a political challenge in reorganising services to meet
the specialised commissioning speciﬁcation. Also inevitable is a
degree of uncertainty around capacity and waiting times as the
number of patients meeting the referral criteria could exceed
expectations, particularly if the specialist units receive inappro-
priate referrals.
It should also be noted that specialist commissioning for
severe asthma only applies to adults. Children with severe
asthma will continue to be seen in a larger number of paediatric
centres which operate as per the precommissioning model of
adult severe asthma outlined above. In order to bridge this gap,
all paediatric severe asthma services must be aligned to and
work closely with a commissioned adult severe asthma service
to ensure the smooth transition of care of young people (YP)
with severe asthma to the right adult service. Not all YP will
require transition to an adult severe asthma service; some may
continue to be followed up in their local secondary care asthma
clinic and some in primary care. The decision as to the most
appropriate setting for ongoing care should be made jointly by
the adult and paediatric teams.
SPECIALISED COMMISSIONING AS AN OPPORTUNITY
The specialised commissioning process represents a pivotal
moment for asthma care in the UK. The conversations, colla-
borations and service developments associated with the process
represent an opportunity to raise standards through the wide-
spread adoption of standard protocols and procedures and
through the sharing of data and expertise. Asthma clinicians
from across the country recently presented NHSE with a con-
sensus document,12 facilitated by Asthma UK, suggesting how
this opportunity could be maximised to provide high-quality,
accessible care to all patients while addressing local practical
Figure 2 Example of a ‘Hub and Network’ model. The specialist,
‘Hub’, site refers to the centre which is commissioned to provide severe
asthma services (depicted as largest white box). The wider network
sites would supplement the specialised centre, rather than act as an
alternative, and support the central service in delivering the best care
for patients. The wider network might be made up of two types of
sites: ‘satellite’ and ‘peripheral’ (depicted in white and grey,
respectively). Satellite sites would be entrusted a level of responsibility
to provide certain services governed by a contracted service level
agreement with the Hub. The level of responsibility devolved would
vary across networks and individual satellite sites depending on local
needs and the expertise and capacity available at these sites.
Figure 1 Under specialised commissioning, patients ﬁtting the criteria
would be referred to their most geographically convenient regional
specialist unit from either primary, secondary or tertiary care. The
specialist units, based at an unspeciﬁed number of pre-existing centres,
would act as concentrated centres of excellence located around the UK,
with all other severe asthma services decommissioned in their existing
form. To be commissioned as a specialist unit, centres must have
access to all facilities outlined in the speciﬁcation4 required to deliver
full multidisciplinary team assessments over 2-day case visits and must
be led by at least two consultant respiratory physicians with a special
interest in severe asthma.
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barriers to its implementation. This document argues that spe-
cialised commissioning can be effectively delivered though net-
worked models of care similar to those that have proven to be
effective for other problems (eg, stroke, burns and trauma).
Each area of England will need to develop their own service
model for specialised commissioning depending on geography,
local population and historical services. A proposed model is
the ‘Hub and Network’ which involves a specialist unit commis-
sioned to provide severe asthma services in line with the service
speciﬁcation (ﬁgure 2). This unit will support, and be supported
by, surrounding primary and secondary care services. These
network sites will agree to follow standard protocols for investi-
gation, treatment and referral with ‘common knowledge’ that all
participants are accountable for following agreed pathways.
Management of patients ﬁtting the criteria for specialist treat-
ment will be facilitated by video-linked MDT discussion, in a
similar model to lung cancer services, where assessment is
carried out locally and treatment carried out in specialist centres
after regional MDT discussion. These processes will ensure the
gatekeeping of high-cost or toxic therapies, allow some com-
promise in opposing views on centralising services and deliver
more patient-centred care through local services. Some sites will
also be contracted to undertake clearly deﬁned specialist activ-
ities to a predetermined, audited, high standard. In this way,
patient experience and the needs of the local population can be
prioritised and standardised. Specialist activity can be focused in
centres of excellence rather than those of geographical conveni-
ence, while also recognising and rewarding expertise outside
commissioned centres. A network approach enables service and
outcome improvements through capturing and analysing per-
formance data and through engagement with patients across the
pathway. In the longer term, improvements will also be seen
from the improved patient and clinical education structure and
through networks facilitating clinical research. This might strike
some as a naïve vision, but if there is not a collective and signiﬁ-
cant change in our approach to asthma management, outcomes
will continue to be mediocre in relation to both other countries
and the investment made by the NHS. Ensuring that children
and adolescents with asthma have equitable access to specialised
services is the next challenge.
CONCLUSION
There is tremendous potential to improve the care of people
with severe asthma in the UK, and this could be catalysed by the
specialised commissioning process. If we are to disperse excel-
lence throughout the entire patient pathway, clinicians must
retain a broad perspective and collegiate approach, while com-
missioners must acknowledge the complex environment in
which they are operating. Excellence in severe asthma care and
improved outcomes across the country will only be achieved if
it is seamlessly integrated with collective improvements in all
aspects of asthma services.
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